Search

Peter D. Le

Examiner (ID: 14873, Phone: (571)270-5382 , Office: P/2488 )

Most Active Art Unit
2488
Art Unit(s)
2488
Total Applications
777
Issued Applications
611
Pending Applications
73
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1169679 [patent_doc_number] => 06753320 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'LIF for use in modulating inflammation and pain' [patent_app_type] => B1 [patent_app_number] => 09/712028 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 15271 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753320.pdf [firstpage_image] =>[orig_patent_app_number] => 09712028 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/712028
LIF for use in modulating inflammation and pain Nov 12, 2000 Issued
Array ( [id] => 1265861 [patent_doc_number] => 06660904 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'HIV and CD4 transgenic animals and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/685256 [patent_app_country] => US [patent_app_date] => 2000-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 22433 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660904.pdf [firstpage_image] =>[orig_patent_app_number] => 09685256 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/685256
HIV and CD4 transgenic animals and uses therefor Oct 9, 2000 Issued
09/685666 COMPOSITIONS AND METHODS OF MAKING SPERMATOGONIAL STEM CELLS Oct 9, 2000 Abandoned
Array ( [id] => 7964461 [patent_doc_number] => 06680196 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'Gene that is amplified and overexpressed in cancer and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/647143 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 16838 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680196.pdf [firstpage_image] =>[orig_patent_app_number] => 09647143 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/647143
Gene that is amplified and overexpressed in cancer and methods of use thereof Sep 26, 2000 Issued
Array ( [id] => 1083188 [patent_doc_number] => 06833489 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-21 [patent_title] => 'Assays for modulators of prolyl-4-hydroxylase' [patent_app_type] => B1 [patent_app_number] => 09/663805 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3169 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833489.pdf [firstpage_image] =>[orig_patent_app_number] => 09663805 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/663805
Assays for modulators of prolyl-4-hydroxylase Sep 14, 2000 Issued
Array ( [id] => 948661 [patent_doc_number] => 06962696 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-08 [patent_title] => 'Compositions and methods for tumor-targeted delivery of effector molecules' [patent_app_type] => utility [patent_app_number] => 09/645415 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 47200 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962696.pdf [firstpage_image] =>[orig_patent_app_number] => 09645415 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/645415
Compositions and methods for tumor-targeted delivery of effector molecules Aug 23, 2000 Issued
Array ( [id] => 1265365 [patent_doc_number] => 06656449 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Methods of screening agents for activity using teleosts' [patent_app_type] => B1 [patent_app_number] => 09/645432 [patent_app_country] => US [patent_app_date] => 2000-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 29 [patent_no_of_words] => 37449 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656449.pdf [firstpage_image] =>[orig_patent_app_number] => 09645432 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/645432
Methods of screening agents for activity using teleosts Aug 22, 2000 Issued
09/622490 Transgenic mouse having a lacz reporter gene under the control of the n-cam promoter useful for identifying n-cam modulators, methods and compositions Aug 16, 2000 Abandoned
Array ( [id] => 1164100 [patent_doc_number] => 06759393 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Growth hormone and growth hormone releasing hormone compositions' [patent_app_type] => B1 [patent_app_number] => 09/628730 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23791 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759393.pdf [firstpage_image] =>[orig_patent_app_number] => 09628730 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/628730
Growth hormone and growth hormone releasing hormone compositions Jul 27, 2000 Issued
09/509668 TRANSGENIC MODEL COMPRISING TCR ALPHA AND BETA CHAINS Jul 24, 2000 Abandoned
09/446808 MAMMAL WITH INHIBITION OF THE POLY(ADP RIBOSE) POLYMERASE AND METHOD FOR USING SAME TO IDENTIFY CANCERIGENIC AGENTS Jul 20, 2000 Abandoned
Array ( [id] => 1049977 [patent_doc_number] => 06861254 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-01 [patent_title] => 'Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor' [patent_app_type] => utility [patent_app_number] => 09/557262 [patent_app_country] => US [patent_app_date] => 2000-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24867 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861254.pdf [firstpage_image] =>[orig_patent_app_number] => 09557262 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/557262
Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor Apr 23, 2000 Issued
09/485015 Insect control gene dsf and methods of use Apr 13, 2000 Abandoned
09/513575 COMPOSITIONS AND METHODS FOR NON-TARGETED ACTIVATION OF ENDOGENOUS GENES Feb 24, 2000 Abandoned
09/496499 Compositions and methods for treating lysosomal storage disease Feb 1, 2000 Abandoned
Array ( [id] => 1397335 [patent_doc_number] => 06545198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Transgenically produced prolactin' [patent_app_type] => B1 [patent_app_number] => 09/490657 [patent_app_country] => US [patent_app_date] => 2000-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17838 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545198.pdf [firstpage_image] =>[orig_patent_app_number] => 09490657 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/490657
Transgenically produced prolactin Jan 23, 2000 Issued
Array ( [id] => 1410430 [patent_doc_number] => 06524818 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/484997 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 98 [patent_no_of_words] => 62557 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524818.pdf [firstpage_image] =>[orig_patent_app_number] => 09484997 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/484997
Compositions and methods for non-targeted activation of endogenous genes Jan 17, 2000 Issued
Array ( [id] => 1299220 [patent_doc_number] => 06623958 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/484996 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 101 [patent_no_of_words] => 62543 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623958.pdf [firstpage_image] =>[orig_patent_app_number] => 09484996 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/484996
Compositions and methods for non-targeted activation of endogenous genes Jan 17, 2000 Issued
Array ( [id] => 1179533 [patent_doc_number] => 06740503 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/484317 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 62558 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740503.pdf [firstpage_image] =>[orig_patent_app_number] => 09484317 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/484317
Compositions and methods for non-targeted activation of endogenous genes Jan 17, 2000 Issued
Array ( [id] => 1410556 [patent_doc_number] => 06524824 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => B1 [patent_app_number] => 09/481355 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 101 [patent_no_of_words] => 62555 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524824.pdf [firstpage_image] =>[orig_patent_app_number] => 09481355 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/481355
Compositions and methods for non-targeted activation of endogenous genes Jan 11, 2000 Issued
Menu